Source: Annual Congress 2012 - Unimodal treatment for nonsmall cell lung cancer: dawn of a renaissance?



Rating:

Share or cite this content

Citations should be made in the following way:
A.P. Meert (Brussels, Belgium). Targeted substances and no more?. Annual Congress 2012 - Unimodal treatment for nonsmall cell lung cancer: dawn of a renaissance?

Member's Comments

No comment yet.

Related content which might interest you: What are the targets? Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Targeted therapies for lung cancer: how did the game begin? Source: Breathe 2016; 12: 177-179 Year: 2016 Antiviral drugs: which and when? Source: Annual Congress 2006 - Influenza: from avian flu to pandemia? Year: 2006 Investigating the steroids and long-acting β2-agonists combination: why do we need more? Source: Eur Respir J 2004; 23: 501-502 Year: 2004 Targeting mucus as a new therapeutic avenue? Source: Annual Congress 2011 - Mucus in airway diseases: bad or good partner? Year: 2011 Do we need new antibiotics? Source: Annual Congress 2009 - Antibiotics and the lung Year: 2009 Cleaning agents: how they look like and how might they cause respiratory harm? Source: International Congress 2018 – Cleaning agent exposures: are they really harmful to lung health? Year: 2018 Immunotherapy: when, who and which drug? Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer Year: 2018 Biodiesel: is it any safer to use? Source: International Congress 2018 – Occupational and environmental lung diseases: mechanisms, biomarkers and causation Year: 2018 To tracheostomize or not to tracheostomize? Source: Eur Respir J 2005; 26: Suppl. 49, 393s Year: 2005 Vitamin C against the harmful effects of prenatal passive smoking: when all other options fail? Source: Eur Respir J, 56 (6) 2002770; 10.1183/13993003.02770-2020 Year: 2020 Anti-tuberculosis drugs : what is new? / Nouveaux médicaments antituberculeux: quoi de neuf ? Source: International Congress 2018 – French Programme 2018: Part II Year: 2018 Biomarkers of inhalation - what’s new and what is useful in smoking cessation and reduction trials? Source: Annual Congress 2003 - PG20 - Smoking reduction and smoking cessation - an update and suggestions for future studies Year: 2003 Targeting targeted therapies: more choices and the best sequences Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer Year: 2018 Pleural interventions: less is more? Source: Eur Respir Monogr 2020; 87: 90-18 Year: 2020 Whither pulmonary rehabilitation? Will alternative modes help or hurt? Source: Eur Respir J, 52 (4) 1801678; 10.1183/13993003.01678-2018 Year: 2018 Inhaled antibiotics: a new tool? Source: Annual Congress 2009 - Antibiotics and the lung Year: 2009